CD274 and neoplasm: The mechanism of ICB in SCLC involves disrupting PD-1/PD-L1 interactions, thereby restoring T-cell-mediated tumor cytotoxicity and counteracting the immunosuppressive TIME characteristic of SCLC (26, 32).